Experimental drug offered for rare Disease's painful wounds
NCT ID NCT04914247
Summary
This program provides access to an investigational drug called selexipag (Uptravi) for patients with Buerger's disease who have wounds that won't heal. Buerger's disease is a rare condition that causes blocked blood vessels, often in the arms and legs, leading to painful sores. The program aims to see if this medication can help improve blood flow and promote wound healing in these difficult cases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HEALING WOUND are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.